Effects of Kimchi Supplementation on Gut Microbiota, DNA Methylation and Serum Proteomes
Effects of Polyphenol and Lactobacillus Rhamnosus Supplementation in Fermented Vegetables (Kimchi) on Gut Microbiota, DNA Methylation and Serum Proteomes in Overweight and Obese Women
1 other identifier
interventional
90
1 country
1
Brief Summary
Participants will ask to answer questionnaire related to general characteristic, lifestyle, dietary pattern and undergo physical examination and measurement of body composition. The subjects will be divided into 2 groups: healthy control and intervention. The intervention group was divided into 3 subgroups: the fermented vegetable (kimchi) group, the kimchi supplemented with polyphenol (Vitexin) group, or the kimchi supplemented with probiotic (Lactobacillus rhamnosus) group. The intervention group will be instructed to consume 1 pack of kimchi per day (50 g/pack) with lunch for 2 months.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable obesity
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 21, 2023
CompletedStudy Start
First participant enrolled
June 15, 2023
CompletedFirst Posted
Study publicly available on registry
June 23, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2024
CompletedJune 23, 2023
June 1, 2023
6 months
May 21, 2023
June 15, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
ฺBMI
changes in BMI for evaluating obesity at 2 months from baseline
2 months
gut bacterial flora
Changes and differences of the gut bacterial flora will be addressed in detail, e.g. changes in concentration of specific bacterial groups (e.g. Lactobacillus) before and after the intervention period.
2 months
Secondary Outcomes (2)
DNA methylation of inflammation and anti-inflammation gene
2 months
Serum proteome
2 months
Other Outcomes (1)
The differences between the treatment groups and the non-obese group for exploratory variables
baseline
Study Arms (3)
Supplementation-standard
ACTIVE COMPARATORSupplementation with Kimchi 50 gram daily for two months
Supplementation with probiotic
EXPERIMENTALSupplementation with Kimchi plus LGG 50 gram daily for two months
Supplementation with polyphenol
EXPERIMENTALSupplementation with Kimchi plus polyphenol 50 gram daily for two months
Interventions
Fermented Vegetables (Kimchi) supplementation with 50 gm daily for two months and effects of DNA methylation, serum proteome and microbiota
Supplementation with Kimchi plus LGG 50 grams daily for two months
Supplementation with Kimchi plus polyphenol 50 grams daily for two months
Eligibility Criteria
You may qualify if:
- age 35-50 years, BMI of ≥23 kg/m2, presence or absence of metabolic syndrome (not treated by medication) according to the National Cholesterol Education Program (NCEP ATPIII 2007), in collaboration with the International Diabetes Federation (IDF) and the World Health Organization (WHO), metabolic syndrome
You may not qualify if:
- participants declined or withdrew, history of taking antibiotics in the 12 weeks prior to the project, history of using prebiotics or probiotic supplements on a regular basis, history of eating foods in these groups regularly, including yogurt, sour milk, fermented vegetables, and fermented fruits, history of taking drugs or weight loss products in the previous 6 months, history of diarrhea or constipation regularly, history of cure for ulcerative colitis, history of underlying disease that requires continuous medication, history of taking laxatives regularly, history of severe gastrointestinal disease, and history of illnesses such as thyroid disease, cancer, autoimmune diseases, kidney disease and hypertension etc.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Jintana Sirivarasai
Bangkok, 10400, Thailand
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jintana Sirivarasai, Ph.D
Ramathibodi Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 21, 2023
First Posted
June 23, 2023
Study Start
June 15, 2023
Primary Completion
November 30, 2023
Study Completion
July 31, 2024
Last Updated
June 23, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
- Time Frame
- starting 12 months after publication
- Access Criteria
- After summary data are published and others can access via journal website
all IPD that underlie results in a publication